MedPage Today Cardiovascular

  • Updated:Feb 24,2014
  • Skull Size Tied to Disability Risk in MS

    Sep 18, 2014 9:47 AM | BOSTON (MedPage Today) -- Multiple sclerosis patients with larger intracranial volumes -- a measure of their lifetime maximal brain size -- scored better on cognition and physical function tests than those with smaller skull sizes.
  • Morning Break: Scots Vote, What Happens to NHS?

    Sep 18, 2014 8:45 AM | (MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff.
  • Diabetes Device Regulation Lagging

    Sep 17, 2014 12:00 PM | VIENNA (MedPage Today) -- Diabetes experts in the U.S. are joining the European call for better regulation of diabetes devices.
  • Pump Beats Shots in Swedish Diabetes Registry

    Sep 17, 2014 11:15 AM | VIENNA (MedPage Today) -- Type 1 diabetes patients on pump therapy may have better long-term outcomes than those taking multiple injections of insulin each day, including a lower risk of death, Swedish researchers reported here.
  • TCT: PFO No Panacea for Migraine

    Sep 16, 2014 6:20 PM | WASHINGTON (MedPage Today) -- Percutaneous patent foramen ovale (PFO) closure did not significantly reduce the number of monthly migraine days compared with medical treatment, researchers reported here.
  • TCT: Renal Denervation No Better Than Sham

    Sep 16, 2014 3:14 PM | WASHINGTON (MedPage Today) -- In a small study using ambulatory systolic pressure readings as an endpoint, renal sympathetic denervation did not achieve a benefit in patients with mild but treatment-resistant hypertension.
  • Fatty Dairy May Keep T2D at Bay

    Sep 16, 2014 12:19 PM | VIENNA (MedPage Today) -- Eating a lot of fatty dairy products, such as cream and fermented milk, seemed to lower the risk of type 2 diabetes development, Swedish researchers said here.
  • Insulin Responses Blunted in South Asians Pre-T2D

    Sep 16, 2014 11:49 AM | VIENNA (MedPage Today) -- Before they were even diagnosed with type 2 diabetes, South Asians showed a sharper decline in insulin sensitivity and less of a bump in insulin secretion compared with white patients.
  • Hillary to TCT: Fee-for-Service Days Are Numbered

    Sep 16, 2014 11:30 AM | WASHINGTON (MedPage Today) -- Hillary Clinton says fee-for-service medicine is probably an idea whose time has passed.
  • Exercise Keeps BP Steady Despite Age (CME/CE)

    Sep 16, 2014 11:04 AM | (MedPage Today) -- A progressively rising blood pressure trajectory is not an inevitable part of aging in men who remain active and maintain high levels of cardiorespiratory fitness, a prospective, population-based study found.
  • TCT: No Harm, No Foul With Triple Therapy (CME/CE)

    Sep 15, 2014 4:37 PM | WASHINGTON (MedPage Today) -- Limiting the length of triple therapy for stent patients who require anticoagulation does not increase the benefit or reduce the risk in this population, researchers reported.
  • TCT: Bivalirudin Cuts Bleeding in PCI

    Sep 15, 2014 4:15 PM | WASHINGTON (MedPage Today) -- A prolonged infusion of bivalirudin (AngioMax) around percutaneous coronary intervention reduced bleeding compared with heparin, with or without glycoprotein IIb/IIIa inhibition, a Chinese trial showed.
  • Generic Statins Boost Patient Adherence, Outcomes

    Sep 15, 2014 4:04 PM | (MedPage Today) -- Going off-brand for statin medication modestly improved adherence and cardiovascular outcomes, an observational study showed.
  • TCT: DAPT for 6 Months Safe and Effective (CME/CE)

    Sep 15, 2014 3:18 PM | WASHINGTON (MedPage Today) -- Six months of dual antiplatelet therapy after implantation of a second generation drug-eluting stent (DES) prevented major cardiovascular events just as effectively as 12 months.
  • GLP-1 Plus Insulin Betters Glycemic Control

    Sep 15, 2014 12:01 PM | (MedPage Today) -- The combination of GLP-1 agonists and basal insulin beat other type 2 diabetes treatments at lowering HbA1c and improving glycemic control, researchers found.